BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23876364)

  • 1. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.
    Hyder O; Dodson RM; Sachs T; Weiss M; Mayo SC; Choti MA; Wolfgang CL; Herman JM; Pawlik TM
    Surgery; 2014 Jan; 155(1):85-93. PubMed ID: 23876364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsurgical radiotherapy in stage IIIB gallbladder cancer patients with one to three lymph nodes metastases: A propensity score matching analysis.
    Cai YL; Lin YX; Xiong XZ; Ye H; Li FY; Cheng NS
    Am J Surg; 2021 Mar; 221(3):642-648. PubMed ID: 32859350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
    Kresl JJ; Schild SE; Henning GT; Gunderson LL; Donohue J; Pitot H; Haddock MG; Nagorney D
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):167-75. PubMed ID: 11777635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease.
    Mojica P; Smith D; Ellenhorn J
    J Surg Oncol; 2007 Jul; 96(1):8-13. PubMed ID: 17516546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.
    Wang J; Narang AK; Sugar EA; Luber B; Rosati LM; Hsu CC; Fuller CD; Pawlik TM; Miller RC; Czito BG; Tuli R; Crane CH; Ben-Josef E; Thomas CR; Herman JM
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1100-6. PubMed ID: 26224402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater.
    Miura JT; Jayakrishnan TT; Amini A; Johnston FM; Tsai S; Erickson B; Quebbeman EJ; Christians KK; Evans DB; Gamblin TC; Turaga KK
    J Gastrointest Surg; 2014 Nov; 18(11):2003-8. PubMed ID: 25159502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
    Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
    J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
    Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
    Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
    Luo Y
    Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.
    Hoffman KE; Neville BA; Mamon HJ; Kachnic LA; Katz MS; Earle CC; Punglia RS
    Cancer; 2012 Jan; 118(1):248-57. PubMed ID: 21692071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database.
    Lim YJ; Kim K
    Int J Clin Oncol; 2018 Jun; 23(3):473-481. PubMed ID: 29260430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?
    Hari DM; Howard JH; Leung AM; Chui CG; Sim MS; Bilchik AJ
    HPB (Oxford); 2013 Jan; 15(1):40-8. PubMed ID: 23216778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
    Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
    J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer-Population-Based Analysis with Propensity Score Matching.
    Lim YJ; Kim K; Chie EK; Kim B; Ha SW
    J Gastrointest Surg; 2015 Dec; 19(12):2183-91. PubMed ID: 26376994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.
    Mayo SC; Shore AD; Nathan H; Edil B; Wolfgang CL; Hirose K; Herman J; Schulick RD; Choti MA; Pawlik TM
    J Gastrointest Surg; 2010 Oct; 14(10):1578-91. PubMed ID: 20824371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer.
    Todoroki T; Kawamoto T; Otsuka M; Koike N; Yoshida S; Takada Y; Adachi S; Kashiwagi H; Fukao K; Ohara K
    Hepatogastroenterology; 1999; 46(27):1585-91. PubMed ID: 10430299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.